Endo International PLC (NASDAQ:ENDP) (TSE:ENL) – Stock analysts at Svb Leerink cut their Q2 2019 earnings estimates for shares of Endo International in a research note issued to investors on Thursday, April 18th, according to Zacks Investment Research. Svb Leerink analyst A. Fadia now expects that the company will post earnings per share of $0.52 for the quarter, down from their prior estimate of $0.53. Svb Leerink has a “Market Perform” rating on the stock. Svb Leerink also issued estimates for Endo International’s Q3 2019 earnings at $0.59 EPS, Q4 2019 earnings at $0.67 EPS, FY2022 earnings at $1.10 EPS and FY2023 earnings at $1.12 EPS.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. The company had revenue of $720.00 million during the quarter, compared to analysts’ expectations of $692.31 million. Endo International had a negative return on equity of 199.18% and a negative net margin of 18.35%. The firm’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 EPS.
Shares of NASDAQ ENDP traded up $0.05 during midday trading on Friday, hitting $8.06. The stock had a trading volume of 4,070,899 shares, compared to its average volume of 2,701,650. The firm has a market capitalization of $1.81 billion, a P/E ratio of 2.79 and a beta of 1.12. Endo International has a 1-year low of $5.92 and a 1-year high of $18.50.
A number of institutional investors have recently added to or reduced their stakes in ENDP. Norges Bank acquired a new position in Endo International during the 4th quarter worth approximately $21,218,000. Teachers Advisors LLC raised its position in shares of Endo International by 230.1% in the 3rd quarter. Teachers Advisors LLC now owns 1,468,025 shares of the company’s stock valued at $24,707,000 after purchasing an additional 1,023,350 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Endo International by 83,573.5% in the 1st quarter. Acadian Asset Management LLC now owns 771,470 shares of the company’s stock valued at $6,194,000 after purchasing an additional 770,548 shares in the last quarter. Canada Pension Plan Investment Board raised its position in shares of Endo International by 143,723.6% in the 4th quarter. Canada Pension Plan Investment Board now owns 730,624 shares of the company’s stock valued at $5,333,000 after purchasing an additional 730,116 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund acquired a new position in shares of Endo International in the 4th quarter valued at approximately $76,000. 95.03% of the stock is currently owned by hedge funds and other institutional investors.
Endo International Company Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Further Reading: P/E Growth (PEG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.